Combination Therapy Comprising A CCR5 Antagonist, A HIV-1 Protease Inhibtior and a Pharmacokinetic Enhancer

• 收藏
• 分享

专利权人:

Hernan Valdez;Randy Tressler

发明人:

Randy Tressler,Hernan Valdez

申请号：

US13638999

公开号：

US20130023496A1

申请日:

2011.03.30

申请国别(地区):

US

年份:

2013

代理人:

摘要：

The present invention discloses a novel combination therapy for HIV-1 treatment relying on a combination of at least one CCR5 antagonist, at least one HIV-1 protease inhibitor and at least one pharmacokinetic enhancer of said at least one CCR5 antagonist and/or at least one HIV-1 protease inhibitor. The combination is intended for use in oral treatment of a disorder selected from the group consisting of HIV-1 infection, retroviral infections genetically related to HIV and AIDS, in a treatment-naïve patient infected with CCR5 tropic HIV-1 virus.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/